|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 213/02 | |
| C07D 401/02 | |||
| A61K 31/44 |
| (11) | Patento numeris | 1838674 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06718419.2 |
| Europos patento paraiškos padavimo data | 2006-01-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-03-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/001341 |
| Data | 2006-01-13 |
| (87) | Numeris | WO 2006/076644 |
| Data | 2006-07-20 |
| (30) | Numeris | Data | Šalis |
| 644103 P | 2005-01-14 | US | |
| 742821 P | 2005-12-06 | US | |
| 750985 P | 2005-12-16 | US |
| (72) |
UNGASHE, Solomon, US
WRIGHT, John, Jessen, AU
ZENG, Yibin, US
BADAK, Arindrajit, US
CHARVAT, Trevor, T., US
DAIRAGHI, Daniel, US
HANSEN, Derek, US
JIN, Jeff, US
MOORE, Jimmie, US
PENNELL, Andrew M.K., US
PUNNA, Sreenivas, US
WEI, Zheng, US
|
| (73) |
ChemoCentryx, Inc.,
850 Maude Avenue, Mountain View California 94043,
US
|
| (54) | HETEROARYL SULFONAMIDES AND CCR2 |
| HETEROARYL SULFONAMIDES AND CCR2 |